Ohad Karnieli
Founder & Chief Executive Officer ADVA Biotechnology
A well-known international expert in cell therapy. Dr. Karnieli is the founder and CEO of ADVA Biotechnologies and the former CEO of Atvio Biotech, a leading Innovation center for cell & gene therapy that was sold to Orgenesis Inc. in 2018. Former VP of Technology & Manufacturing at Pluristem Therapeutics, and the former VP of the medical device at Goji Solutions. Dr. Karnieli served as the chair of the process & product development committee of the International Society for Cellular Therapies, as an expert member in the ISO TC276 Biotechnology standard committee, and was the former chair of the science and technology committee of the Alliance for Regenerative Medicine.
Seminars
Thursday 16th July 2026
Smart. Flexible. Cost-effective. Next-generation cell therapy manufacturing that combines process control, real-time insight, and unmatched quality. Simpler than you would imagine.
9:30 am
- The future of smart, automated cell therapy manufacturing
- Achieving better quality, lower costs, and greater process control
- Moving from manual operations to data-driven production
- Enabling scalable manufacturing for broader patient access
